Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 38% ± 19% | |
microglial cell | 5 studies | 33% ± 9% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 6% | |
naive B cell | 3 studies | 21% ± 5% | |
B cell | 3 studies | 19% ± 1% | |
glutamatergic neuron | 3 studies | 32% ± 21% | |
natural killer cell | 3 studies | 21% ± 4% | |
myeloid cell | 3 studies | 30% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 39% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 4590.70 | 653 / 653 | 100% | 58.66 | 605 / 605 |
skin | 100% | 2858.25 | 1803 / 1809 | 100% | 48.58 | 471 / 472 |
esophagus | 100% | 2609.33 | 1444 / 1445 | 99% | 24.18 | 182 / 183 |
brain | 100% | 3719.69 | 2638 / 2642 | 99% | 27.50 | 701 / 705 |
kidney | 100% | 2420.51 | 89 / 89 | 99% | 22.50 | 894 / 901 |
prostate | 100% | 2453.86 | 245 / 245 | 99% | 19.14 | 497 / 502 |
adrenal gland | 100% | 4721.58 | 258 / 258 | 99% | 26.72 | 227 / 230 |
breast | 100% | 2219.71 | 458 / 459 | 99% | 24.62 | 1104 / 1118 |
uterus | 100% | 5247.54 | 170 / 170 | 98% | 25.50 | 452 / 459 |
intestine | 100% | 3407.59 | 966 / 966 | 98% | 20.96 | 516 / 527 |
stomach | 99% | 1911.65 | 356 / 359 | 98% | 20.02 | 280 / 286 |
lung | 99% | 2876.63 | 574 / 578 | 98% | 21.14 | 1127 / 1155 |
ovary | 100% | 4685.21 | 180 / 180 | 96% | 17.18 | 411 / 430 |
bladder | 100% | 2235.67 | 21 / 21 | 95% | 17.64 | 477 / 504 |
pancreas | 87% | 996.38 | 285 / 328 | 98% | 17.83 | 174 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 246.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 80.37 | 29 / 29 |
muscle | 100% | 7843.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5134.35 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.34 | 1 / 1 |
adipose | 100% | 2473.73 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1568.64 | 1317 / 1335 | 0% | 0 | 0 / 0 |
liver | 35% | 301.03 | 79 / 226 | 63% | 6.34 | 255 / 406 |
heart | 97% | 2862.97 | 839 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 3267.91 | 887 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0006606 | Biological process | protein import into nucleus |
GO_0005634 | Cellular component | nucleus |
Gene name | FAM53B |
Protein name | Protein FAM53B (Protein simplet) |
Synonyms | KIAA0140 SMP |
Description | FUNCTION: Acts as a regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) nuclear localization. . |
Accessions | ENST00000337318.8 [Q14153-1] Q14153 ENST00000392754.7 [Q14153-1] ENST00000280780.6 [Q14153-2] |